Annual Revenue
$163.91 M
+$53.67 M+48.68%
December 31, 2023
Summary
- As of February 7, 2025, XERS annual revenue is $163.91 million, with the most recent change of +$53.67 million (+48.68%) on December 31, 2023.
- During the last 3 years, XERS annual revenue has risen by +$143.48 million (+702.12%).
- XERS annual revenue is now at all-time high.
Performance
XERS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$54.27 M
+$6.20 M+12.91%
September 30, 2024
Summary
- As of February 7, 2025, XERS quarterly revenue is $54.27 million, with the most recent change of +$6.20 million (+12.91%) on September 30, 2024.
- Over the past year, XERS quarterly revenue has increased by +$5.95 million (+12.31%).
- XERS quarterly revenue is now at all-time high.
Performance
XERS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$187.36 M
+$5.95 M+3.28%
September 30, 2024
Summary
- As of February 7, 2025, XERS TTM revenue is $187.36 million, with the most recent change of +$5.95 million (+3.28%) on September 30, 2024.
- Over the past year, XERS TTM revenue has increased by +$34.69 million (+22.72%).
- XERS TTM revenue is now at all-time high.
Performance
XERS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
XERS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.7% | +12.3% | +22.7% |
| 3 y3 years | +702.1% | +12.3% | +22.7% |
| 5 y5 years | +6664.9% | +12.3% | +22.7% |
XERS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +230.5% | at high | +153.3% | at high | +277.8% |
| 5 y | 5-year | at high | +5921.8% | at high | +3137.9% | at high | +6783.2% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Xeris Biopharma Holdings Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $54.27 M(+12.9%) | $187.36 M(+3.3%) |
| Jun 2024 | - | $48.06 M(+18.3%) | $181.41 M(+5.9%) |
| Mar 2024 | - | $40.64 M(-8.5%) | $171.36 M(+4.5%) |
| Dec 2023 | $163.91 M(+48.7%) | $44.39 M(-8.1%) | $163.91 M(+7.4%) |
| Sep 2023 | - | $48.32 M(+27.1%) | $152.67 M(+13.9%) |
| Jun 2023 | - | $38.01 M(+14.5%) | $134.07 M(+10.5%) |
| Mar 2023 | - | $33.20 M(+0.2%) | $121.37 M(+10.1%) |
| Dec 2022 | $110.25 M(+122.3%) | $33.14 M(+11.5%) | $110.25 M(+11.9%) |
| Sep 2022 | - | $29.73 M(+17.5%) | $98.53 M(+23.4%) |
| Jun 2022 | - | $25.31 M(+14.6%) | $79.87 M(+25.8%) |
| Mar 2022 | - | $22.07 M(+3.0%) | $63.47 M(+28.0%) |
| Dec 2021 | $49.59 M(+142.7%) | $21.43 M(+93.8%) | $49.59 M(+39.6%) |
| Sep 2021 | - | $11.06 M(+24.2%) | $35.53 M(+4.9%) |
| Jun 2021 | - | $8.91 M(+8.7%) | $33.87 M(+25.5%) |
| Mar 2021 | - | $8.20 M(+11.2%) | $27.00 M(+31.8%) |
| Dec 2020 | $20.43 M | $7.37 M(-21.6%) | $20.48 M(+36.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $9.40 M(+363.9%) | $14.97 M(+154.6%) |
| Jun 2020 | - | $2.03 M(+20.9%) | $5.88 M(+41.7%) |
| Mar 2020 | - | $1.68 M(-10.1%) | $4.15 M(+52.5%) |
| Dec 2019 | $2.72 M(+12.3%) | $1.86 M(+495.5%) | $2.72 M(+68.3%) |
| Sep 2019 | - | $313.00 K(+5.4%) | $1.62 M(-14.3%) |
| Jun 2019 | - | $297.00 K(+19.8%) | $1.89 M(-21.7%) |
| Mar 2019 | - | $248.00 K(-67.3%) | $2.41 M(-0.6%) |
| Dec 2018 | $2.42 M(+55.7%) | $759.00 K(+30.4%) | $2.42 M(+13.7%) |
| Sep 2018 | - | $582.00 K(-28.9%) | $2.13 M(+24.0%) |
| Jun 2018 | - | $819.00 K(+211.4%) | $1.72 M(+17.3%) |
| Mar 2018 | - | $263.00 K(-43.7%) | $1.47 M(-5.8%) |
| Dec 2017 | $1.56 M(+44.7%) | $467.00 K(+174.7%) | $1.56 M(+42.9%) |
| Sep 2017 | - | $170.00 K(-69.9%) | $1.09 M(+18.5%) |
| Jun 2017 | - | $565.00 K(+59.6%) | $919.00 K(+159.6%) |
| Mar 2017 | - | $354.00 K | $354.00 K |
| Dec 2016 | $1.07 M | - | - |
FAQ
- What is Xeris Biopharma Holdings annual revenue?
- What is the all time high annual revenue for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual revenue year-on-year change?
- What is Xeris Biopharma Holdings quarterly revenue?
- What is the all time high quarterly revenue for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly revenue year-on-year change?
- What is Xeris Biopharma Holdings TTM revenue?
- What is the all time high TTM revenue for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings TTM revenue year-on-year change?
What is Xeris Biopharma Holdings annual revenue?
The current annual revenue of XERS is $163.91 M
What is the all time high annual revenue for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual revenue is $163.91 M
What is Xeris Biopharma Holdings annual revenue year-on-year change?
Over the past year, XERS annual revenue has changed by +$53.67 M (+48.68%)
What is Xeris Biopharma Holdings quarterly revenue?
The current quarterly revenue of XERS is $54.27 M
What is the all time high quarterly revenue for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly revenue is $54.27 M
What is Xeris Biopharma Holdings quarterly revenue year-on-year change?
Over the past year, XERS quarterly revenue has changed by +$5.95 M (+12.31%)
What is Xeris Biopharma Holdings TTM revenue?
The current TTM revenue of XERS is $187.36 M
What is the all time high TTM revenue for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high TTM revenue is $187.36 M
What is Xeris Biopharma Holdings TTM revenue year-on-year change?
Over the past year, XERS TTM revenue has changed by +$34.69 M (+22.72%)